27 September 2021 : Editorial
Editorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)
DOI: 10.12659/MSM.934854
Med Sci Monit 2021; 27:e934854